Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”

被引：0
|
作者：
Haitang Yang
Sean R. R. Hall
Beibei Sun
Feng Yao
机构：
[1] Shanghai Jiao Tong University,Department of Thoracic Surgery, Shanghai Chest Hospital
[2] Gillies McIndoe Research Institute,Institute for Thoracic Oncology, Shanghai Chest Hospital
[3] Shanghai Jiao Tong University,undefined
来源：
British Journal of Cancer | 2021年 / 124卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1177 / 1178
页数：1
相关论文
共 50 条
  • [31] PD-L1 Protein Expression Is Negative Prognostic Factor in Malignant Pleural Mesothelioma in Central Europe
    Brcic, L.
    Jakopovic, M.
    Kern, I.
    Mohorcic, K.
    Seiwerth, S.
    Grusch, M.
    Rajer, M.
    Buder, A.
    Klikovits, T.
    Laszlo, V.
    Dome, B.
    Hegedus, B.
    Klepetko, W.
    Kolek, V.
    Pirker, R.
    Hoda, M.
    Filipits, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2157 - S2157
  • [32] Detection of PD-L1 expression levels in malignant pleural mesothelioma with a targeted MRI nanoprobe in vivo
    Zhang, Zhenghua
    Tian, Yang
    Gao, Wenjun
    Hu, Yubin
    Luo, Liangping
    Lei, Lichang
    Shen, Shasha
    Han, Dan
    FRONTIERS IN CHEMISTRY, 2024, 12
  • [33] A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma
    Liu, Hanjian
    Yuan, Chuzhi
    Huang, Yongsheng
    Xu, Ning
    ASIAN JOURNAL OF SURGERY, 2023, 46 (12) : 5747 - 5748
  • [34] EFFICACY OF CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY AS TREATMENT OF MALIGNANT PERITONEAL MESOTHELIOMA
    MARKMAN, M
    KELSEN, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (07) : 547 - 550
  • [35] Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy
    Heller, Danielle R.
    Chiuzan, Cody
    Taub, Robert N.
    Leinwand, Joshua C.
    Greene, Allison M.
    Bates, Gleneara E.
    Chabot, John A.
    Kluger, Michael D.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 3818 - 3824
  • [36] Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy
    Elias, Dorninique
    Bedard, Valerie
    Bouzid, Tarek
    Duvillard, Pierre
    Kohneh-Sharhi, Niaz
    Raynard, Bruno
    Goere, Diane
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (10): : 784 - 788
  • [37] Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy (IPHC) for Malignant Peritoneal Mesothelioma (MPM)
    Blackham, A.
    Russell, G.
    Shen, P.
    Stewart, J. H.
    Levine, E. A.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 29 - 30
  • [38] Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy
    Danielle R. Heller
    Cody Chiuzan
    Robert N. Taub
    Joshua C. Leinwand
    Allison M. Greene
    Gleneara E. Bates
    John A. Chabot
    Michael D. Kluger
    Annals of Surgical Oncology, 2017, 24 : 3818 - 3824
  • [39] Continued Uncertainty Regarding Hyperthermic Intraperitoneal Chemotherapy in Malignant Peritoneal Mesothelioma Reply
    Yan, Tristan D.
    Sugarbaker, Paul H.
    Elias, Dominique
    Glehen, Olivier
    Levine, Edward A.
    Moran, Brendan J.
    Deraco, Marcello
    Morris, David L.
    Piso, Pompiliu
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) : E419 - E419
  • [40] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review
    Helm, J. H.
    Miura, J. T.
    Glenn, J. A.
    Marcus, R.
    Larrieux, G.
    Jayakrishnan, T. T.
    Donahue, A. E.
    Tsai, S.
    Gamblin, T. C.
    Turaga, K. K.
    Johnston, F. M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S174 - S174
12345